Pfizer, Inc. has announced that they are ceasing global development and commercialization of Beqvez™, the company’s hemophilia B gene therapy product.Beqvez was designed with bioengineered adeno-associated virus (AAVs) vectors to introduce…
Unite for Bleeding Disorders will occur in 35 cities across the country with one mission: to raise funds and awareness for our local chapter and help us increase education, support services, and advocacy efforts in our community.More Info
Unite for Bleeding Disorders will occur in 35 cities across the country with one mission: to raise funds and awareness for our local chapter and help us increase education, support services, and advocacy efforts in our community.More Info